Loading...
•
Jun 30, 2022
Stryker Q2 2022 Earnings Report
Stryker's Q2 2022 results showed sales growth but earnings were pressured by foreign currency and inflation.
Key Takeaways
Stryker reported a 4.6% increase in net sales to $4.5 billion, with organic net sales increasing by 6.1%. Reported EPS increased by 11.0% to $1.72, while adjusted EPS was $2.25. The company is confident in its full year outlook for revenue.
Reported net sales increased 4.6% to $4.5 billion.
Organic net sales increased 6.1%.
Reported EPS increased 11.0% to $1.72.
Adjusted EPS of $2.25 was in line with 2021.
Forward Guidance
Stryker expects full year 2022 organic net sales growth to be in the range of 8% to 9%. Adjusted net earnings per diluted share are expected to be in the range of $9.30 to $9.50 per share.
Positive Outlook
- Strong order book for capital equipment
- Sales momentum in implant businesses
- Full year 2022 organic net sales growth expected to be in the range of 8% to 9%.
- Continued financial discipline
- Increased sales guidance
Challenges Ahead
- Continued supply chain challenges
- Inflationary environment
- Foreign currency exchange rates will adversely impact net sales by approximately 2% to 3%
- Adjusted net earnings per diluted share will be adversely impacted by approximately $0.25 to $0.30
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...